Unlabelled: Introductıon: Osteoporosis is a common disease, and several factors contribute to its development. Recently, there has been increasing evidence that vitamin K (VK) plays a critical role in maintaining bone strength. Vitamin K serves as a co-factor for the γ-carboxylation of particular proteins to convert specific glutamic acid residues to γ-carboxyglutamic acid residues. This process involves two enzymes, γ-glutamyl carboxylase and vitamin K epoxide reductase (VKORC1). The number of studies investigating the effects of VKORC1 gene mutations on bone mineral density in postmenopausal osteoporosis patients is limited. The aim of this study was to investigate the relationship between the VKORC1 -1639G>A polymorphism and osteoporosis in postmenopausal Turkish women.
Methods: The study group consisted of 176 postmenopausal women with osteoporosis and 140 healthy postmenopausal women. The selection criteria for the healthy controls included non-osteoporotic bone mineral density (BMD) and similar demographic characteristics to the osteoporosis group. The genotyping of the VKORC1 -1639G>A polymorphism was conducted using the restriction fragment-length polymorphism method.
Results: We found that the genotype frequencies of the GG, GA and AA genotypes were 25.6, 64.2 and 10.2% in the patients and 33.6, 55.8 and 10.7% in the controls, respectively. In the patient and control groups, the genotype distribution of the studied locus was found to be non-compatible with Hardy-Weinberg equilibrium. We found a nonsignificant association between the -1639G>A polymorphism in the VKORC1 gene and osteoporosis in postmenopausal Turkish women.
Conclusion: We have shown that the VKORC1 -1639G>A polymorphism is not a risk factor for postmenopausal osteoporosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1871530318666180212100119 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry.
Blood Adv
October 2024
Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Article Synopsis
- Warfarin dosing is affected by individual clinical and genetic factors, with a need to explore genetic variants specific to African populations for better dosing guidance.
- A genome-wide association study (GWAS) focused on 989 warfarin-treated participants from Uganda, South Africa, and Zimbabwe, as well as African American cohorts, found significant genetic variants associated with warfarin response.
- The study highlighted the importance of the CYP2C9 and VKORC1 genes and identified a new potential genetic locus (MALL) that may impact warfarin response, warranting further research to understand its biological relevance.
Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method.
Sci Rep
June 2024
Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, #18 Daoshan Road, Fuzhou, 350001, China.
The purpose of this paper is to study the genetic polymorphisms of related gene loci (CYP2C9*3, VKORC1-1639G > A) based on demographic and clinical factors, and use the maximum a posterior Bayesian method to construct a warfarin individualized dose prediction model in line with the Chinese Han population. Finally, the built model is compared and analyzed with the widely used models at home and abroad. In this study, a total of 5467 INR measurements are collected from 646 eligible subjects in our hospital, and the maximum a posterior Bayesian method is used to construct a warfarin dose prediction that conforms to the Chinese Han population on the basis of the Hamberg model.
View Article and Find Full Text PDFAssociation between gene polymorphisms and initial warfarin therapy in patients after heart valve surgery.
Pharmacol Rep
April 2024
Department of Laboratory Medicine, State Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Center of Laboratory Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Warfarin is widely used for the prevention and treatment of thrombotic events. This study aimed to examine the influence of gene polymorphisms on the early stage of warfarin therapy in patients following heart valve surgery.
Methods: Nine single nucleotide polymorphisms were genotyped using microarray chips, categorizing patients into three groups: normal responders (Group I), sensitive responders (Group II), and highly sensitive responders (Group III).
Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research.
Sci Rep
December 2023
Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Patients who receive heart valve surgery need anticoagulation prophylaxis to reduce the risk of thrombosis. Warfarin often is a choice but its dosage varies due to gene and clinical factors. We aim to study, among them, if there is an interaction between acute kidney injury and two gene polymorphisms from this study.
View Article and Find Full Text PDFFrequencies of VKORC1-1639G>A and rs397509427 in Patients on Warfarin and Healthy Syrian Subjects.
Cardiovasc Ther
December 2023
Department of Pharmaceutics and Pharmaceutical Technology, Program of Clinical and Hospital Pharmacy, Faculty of Pharmacy, Damascus University, Damascus, Syria.
Article Synopsis
- - The study investigates a common gene variation (-1639G>A) that affects vitamin K metabolism and warfarin dosage among Syrian individuals, including both healthy subjects and patients using warfarin for various health issues.
- - Researchers analyzed 138 individuals, finding distinct frequencies of the -1639G>A genotypes between healthy individuals and warfarin patients, with a notable risk increase for those carrying the GG genotype regarding venous thromboembolism (VTE).
- - The findings reveal that the A allele is prevalent among the study's population and is associated with a lower risk of VTE, aligning with frequencies seen in other Mediterranean and Middle Eastern groups, while suggesting that the G allele may contribute to a higher VTE risk globally
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!